Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 7/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28135999 | 1.00 | PYGB (0.44) | PYGBGAACA12CA1CA2 | |
| SCHEMBL8898692 | 0.88 | PYGB (0.46) | PYGBGAACA12CA1CA2 | |
| SCHEMBL7048684 | 0.86 | PYGB (0.49) | PYGBGAACA12CA1CA2 | |
| SCHEMBL31206883 | 0.85 | PYGB (0.46) | PYGBGAACA12CA1CA2 | |
| SCHEMBL29550937 | 0.84 | PYGB (0.49) | PYGBGAACA12CA1CA2 | |
| SCHEMBL28732847 | 0.84 | PYGB (0.48) | PYGBGAACA12CA1CA2 | |
| SCHEMBL3801496 | 0.83 | PYGB (0.51) | PYGBGAACA12CA1CA2 | |
| SCHEMBL20476841 | 0.83 | PYGB (0.51) | PYGBGAACA12CA1CA2 | |
| SCHEMBL28419458 | 0.83 | PYGB (0.51) | PYGBGAACA12CA1CA2 | |
| SCHEMBL2012475 | 0.83 | PYGB (0.51) | PYGBGAACA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119736225-A | Genetically engineered bacterium for efficiently synthesizing melatonin as well as preparation method and application thereof | 上海锐康生物技术研发有限公司 | 2025-04-01 | — | — | CN | claimed |
| WO-2022168650-A1 | HOMOCYSTEINE DERIVATIVE AND METHOD FOR PRODUCING SAME, COMPOSITION, AND ANTI-INFLAMMATORY AGENT | 長瀬産業株式会社 | 2022-08-11 | — | — | WO | claimed |
| CN-106834328-A | A kind of S ribosylhomocysteines lyase gene recombinant expression carrier and its expression and application | 昆明理工大学 | 2017-06-13 | — | — | CN | claimed |
| EP-1282415-A2 | COMPOUNDS AND METHODS FOR REGULATING BACTERIAL GROWTH AND PATHOGENESIS | Princeton University Office of Techology Licensing & I.P. (US) | 2003-02-12 | — | — | EP | claimed |
| WO-2001085664-A2 | COMPOUNDS AND METHODS FOR REGULATING BACTERIAL GROWTH AND PATHOGENESIS | PRINCETON UNIVERSITY (US) | 2001-11-15 | — | — | WO | claimed |
| CN-119736225-A | Genetically engineered bacterium for efficiently synthesizing melatonin as well as preparation method and application thereof | 上海锐康生物技术研发有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-119736225-A | Genetically engineered bacterium for efficiently synthesizing melatonin as well as preparation method and application thereof | 上海锐康生物技术研发有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-117740961-A | Compound analysis method of liquorice and liquorice probiotics fermentation preparation | 北京中医药大学 | 2024-03-22 | — | — | CN | disclosed |
| CN-117045661-B | Application of SAHH reversible inhibitor, pharmaceutical composition and application thereof | 广东医科大学附属医院 | 2024-01-30 | — | — | CN | disclosed |
| CN-117045661-A | Application of SAHH reversible inhibitor, pharmaceutical composition and application thereof | 广东医科大学附属医院 | 2023-11-14 | — | — | CN | disclosed |
| WO-2022168650-A1 | HOMOCYSTEINE DERIVATIVE AND METHOD FOR PRODUCING SAME, COMPOSITION, AND ANTI-INFLAMMATORY AGENT | 長瀬産業株式会社 | 2022-08-11 | — | — | WO | disclosed |
| CN-110325545-A | Attenuated bacteria-based protein delivery | 巴塞尔大学 | 2019-10-11 | — | — | CN | disclosed |
| EP-1417225-A2 | CRYSTALS AND STRUCTURE OF LUXS | Structural Genomix, Inc. (US) | 2004-05-12 | — | — | EP | disclosed |
| WO-2003066880-A2 | METHOD FOR ACCESSING MICROBIAL DIVERSITY | FRAUNHOFER USA INC. (US) | 2003-08-14 | — | — | WO | disclosed |
| WO-2003018046-A1 | CRYSTALS OF LUXP AND COMPLEXES THEREOF | QUOREX PHARMACEUTICALS, INC. (US) | 2003-03-06 | — | — | WO | disclosed |
| EP-1282415-A2 | COMPOUNDS AND METHODS FOR REGULATING BACTERIAL GROWTH AND PATHOGENESIS | Princeton University Office of Techology Licensing & I.P. (US) | 2003-02-12 | — | — | EP | disclosed |
| WO-2002038595-A2 | CRYSTALS AND STRUCTURE OF LUXS | STRUCTURAL GENOMIX, INC. (US) | 2002-05-16 | — | — | WO | disclosed |
| WO-2001085664-A2 | COMPOUNDS AND METHODS FOR REGULATING BACTERIAL GROWTH AND PATHOGENESIS | PRINCETON UNIVERSITY (US) | 2001-11-15 | — | — | WO | disclosed |
| EP-1135144-A1 | COMPOSITIONS AND METHODS FOR REGULATING BACTERIAL PATHOGENESIS | Princeton University (US) | 2001-09-26 | — | — | EP | disclosed |
| WO-2000032152-A2 | COMPOSITIONS AND METHODS FOR REGULATING BACTERIAL PATHOGENESIS | PRINCETON UNIVERSITY (US) | 2000-06-08 | — | — | WO | disclosed |